| 释义 |
- Career
- Scientific misconduct
- Retracted articles
- Books
- See also
- References
- External links
{{Infobox scientist
| name = Bharat B. Aggarwal
| birth_name =
| native_name_lang =
| image =
| image_size =
| alt =
| caption =
| birth_date =
| birth_place =
| death_date =
| signature_alt =
| website =
| footnotes =
| spouse =
| children =
}}Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly those of curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas.[1]In 2012, MD Anderson launched a review of Aggarwal's research after the federal government notified them of allegations of fraud by academic whistleblowers in as many as 65 of Aggarwal's published papers; the concerns were about data images that had been reused and manipulated to represent different results.[2][1][4] He retired at the end of 2015; his departure was not made public until February 2016.[1][6] As of 2019, 28 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected.[2][3] CareerAggarwal holds a Bachelor of Science degree from the University of Delhi (1970), a Master of Science degree from Banares Hindu University (1972) and a Doctor of Philosophy degree from the University of California, Berkeley (1977), all in biochemistry. He completed a postdoctoral fellowship at the University of California, San Francisco and was employed as a scientist at Genentech from 1980 to 1989, where his team characterized the cytokines TNF-alpha and TNF-beta. Aggarwal then served as Chief of the Cytokine Research Section, Department of Clinical Immunology, Bioimmunotherapy, Experimental Therapeutics at MD Anderson Cancer Center of the University of Texas in Houston from 1989 to 2015.[4][5] Aggarwal's research has focused on potential anti-cancer properties of herbs and spices, particularly curcumin, found in the spice turmeric.[4][6] Aggarwal co-founded a company in 2004 called Curry Pharmaceuticals, based in Research Triangle Park, N.C., which was seeking to develop drugs based on synthetic analogs of curcumin.[4][7] SignPath Pharma, a company seeking to develop liposomal formulations of curcumin, in 2013 licensed three patents from Aggarwal related to that approach.[8] Scientific misconductIn 2012, MD Anderson initiated a review of Aggarwal's research after the U.S. Department of Health and Human Services' Office of Research Integrity notified the institution that academic whistleblowers had found evidence of image manipulation in 65 published papers by Aggarwal.[9][10] Aggarwal's lawyer proposed in 2013 legal action against the blog Retraction Watch after they reported several of Aggarwal's article corrections and retractions;[11] no such lawsuit was ever realized. In February 2016, the journal Biochemical Pharmacology retracted seven of Aggarwal's research articles, six of which had Aggarwal as senior or first author,[12] because "the data integrity has become questionable."[1] Also in February 2016, MD Anderson Cancer Center confirmed that Aggarwal had retired from the Center on December 31, 2015.[13][14] In June 2016, following an investigation by MD Anderson Cancer Center, the journal Molecular Pharmacology retracted two papers coauthored by Aggarwal, citing “inappropriate” or “unacceptable” image manipulation.[15] By April 2018, 19 of Aggarwal's articles, published in 7 research journals, were ultimately retracted.[24][1][16][14] In September 2018, an additional nine articles by Aggarwal were retracted in journals published by the American Association for Cancer Research.[17] In February 2018, a cancer conference in Chennai, India co-organized by Aggarwal was promoted with the false claim that it was co-sponsored by MD Anderson Cancer Center.[18][19][20] Retracted articles{{as of|2018|April}}, 19 papers had been retracted.[21][22]- {{cite journal |last1=Aggarwal |first1=BB |last2=Banerjee |first2=S |last3=Bharadwaj |first3=U |last4=Sung |first4=B |last5=Shishodia |first5=S |last6=Sethi |first6=G |title=Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. |journal=Biochemical Pharmacology |date=1 April 2007 |volume=73 |issue=7 |pages=1024–32 |doi=10.1016/j.bcp.2006.12.010 |pmid=17240359|display-authors=1}}{{retracted ||||||pmid=26985469||doi=10.1016/j.bcp.2015.11.012 |||||||||||||intentional=yes}}
- {{cite journal |last1=Tharakan |first1=ST |last2=Inamoto |first2=T |last3=Sung |first3=B |last4=Aggarwal |first4=BB |last5=Kamat |first5=AM |title=Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. |journal=Biochemical Pharmacology |date=15 January 2010 |volume=79 |issue=2 |pages=218–28 |doi=10.1016/j.bcp.2009.08.007 |pmid=19682434 |pmc=3181149|display-authors=1}}{{retracted ||||||pmid=26985467 |pmc=4801035||doi=10.1016/j.bcp.2015.11.010 |||||||||||intentional=yes}}
- {{cite journal |last1=Anand |first1=P |last2=Nair |first2=HB |last3=Sung |first3=B |last4=Kunnumakkara |first4=AB |last5=Yadav |first5=VR |last6=Tekmal |first6=RR |last7=Aggarwal |first7=BB |title=Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. |journal=Biochemical Pharmacology |date=1 February 2010 |volume=79 |issue=3 |pages=330–8 |doi=10.1016/j.bcp.2009.09.003 |pmid=19735646 |pmc=3181156|display-authors=1}}{{retracted ||||||pmid=26985465 |pmc=4809038||doi=10.1016/j.bcp.2015.11.008 |||||||||||||||intentional=yes}}
- {{cite journal |last1=Ravindran |first1=J |last2=Nair |first2=HB |last3=Sung |first3=B |last4=Prasad |first4=S |last5=Tekmal |first5=RR |last6=Aggarwal |first6=BB |title=Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. |journal=Biochemical Pharmacology |date=1 June 2010 |volume=79 |issue=11 |pages=1640–7 |doi=10.1016/j.bcp.2010.01.023 |pmid=20105430 |pmc=2846982|display-authors=1}}{{retracted ||||||pmid=26985468 |pmc=4809052||doi=10.1016/j.bcp.2015.11.011 |||||||||||||intentional=yes}}
- {{cite journal |last1=Yadav |first1=VR |last2=Prasad |first2=S |last3=Kannappan |first3=R |last4=Ravindran |first4=J |last5=Chaturvedi |first5=MM |last6=Vaahtera |first6=L |last7=Parkkinen |first7=J |last8=Aggarwal |first8=BB |title=Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. |journal=Biochemical Pharmacology |date=1 October 2010 |volume=80 |issue=7 |pages=1021–32 |doi=10.1016/j.bcp.2010.06.022 |pmid=20599780 |pmc=2923254|display-authors=1}}{{retracted ||||||pmid=26985464 |pmc=4801114||doi=10.1016/j.bcp.2015.11.007 |||||||||||||||||intentional=yes}}
- {{cite journal |last1=Park |first1=B |last2=Sung |first2=B |last3=Yadav |first3=VR |last4=Chaturvedi |first4=MM |last5=Aggarwal |first5=BB |title=Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway. |journal=Biochemical Pharmacology |date=1 November 2011 |volume=82 |issue=9 |pages=1134–44 |doi=10.1016/j.bcp.2011.07.062 |pmid=21820422 |pmc=3191321|display-authors=1}}{{retracted ||||||pmid=26985463 |pmc=4801115||doi=10.1016/j.bcp.2015.11.006 |||||||||||intentional=yes}}
- {{cite journal |last1=Anand |first1=P |last2=Sung |first2=B |last3=Kunnumakkara |first3=AB |last4=Rajasekharan |first4=KN |last5=Aggarwal |first5=BB |title=Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. |journal=Biochemical Pharmacology |date=15 December 2011 |volume=82 |issue=12 |pages=1901–9 |doi=10.1016/j.bcp.2011.09.001 |pmid=21924245 |pmc=3216474|display-authors=1}}{{retracted ||||||pmid=26985466 |pmc=4801119||doi=10.1016/j.bcp.2015.11.009 |||||||||||intentional=yes}}
- {{cite journal |last1=Anand |first1=P |last2=Sung |first2=B |last3=Kunnumakkara |first3=AB |last4=Rajasekharan |first4=KN |last5=Aggarwal |first5=BB |title=Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. |journal=Biochemical Pharmacology |date=15 December 2011 |volume=82 |issue=12 |pages=1901–9 |doi=10.1016/j.bcp.2011.09.001 |pmid=21924245 |pmc=3216474|display-authors=1}}{{retracted ||||||pmid=26985466 |pmc=4801119||doi=10.1016/j.bcp.2015.11.009 |||||||||||intentional=yes}}
- {{cite journal |last1=Yadav |first1=VR |last2=Prasad |first2=S |last3=Reuter |first3=S |last4=Sung |first4=B |last5=Yamamoto |first5=N |last6=Murakami |first6=A |last7=Aggarwal |first7=BB |title=WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand. |journal=Cancer Letters |date=17 December 2011 |doi=10.1016/j.canlet.2011.12.011 |pmid=22182452 |pmc=3769506|display-authors=1}}
- {{cite journal |last1=Sung |first1=B |last2=Park |first2=B |last3=Yadav |first3=VR |last4=Aggarwal |first4=BB |title=Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. |journal=The Journal of Biological Chemistry |date=9 April 2010 |volume=285 |issue=15 |pages=11498–507 |doi=10.1074/jbc.M109.090209 |pmid=20154087 |pmc=2857028|display-authors=1}}{{retracted |||||||||||||||doi=10.1074/jbc.A109.090209 |pmid=27496961 |pmc=4974403||intentional=yes}}
- {{cite journal |last1=Prasad |first1=S |last2=Yadav |first2=VR |last3=Sundaram |first3=C |last4=Reuter |first4=S |last5=Hema |first5=PS |last6=Nair |first6=MS |last7=Chaturvedi |first7=MM |last8=Aggarwal |first8=BB |title=Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway. |journal=The Journal of Biological Chemistry |date=27 August 2010 |volume=285 |issue=35 |pages=26987–97 |doi=10.1074/jbc.M110.121061 |pmid=20576605 |pmc=2930698|display-authors=1}}{{retracted |||||||||||||||||||||||doi=10.1074/jbc.A110.121061 |pmid=27496962 |pmc=4974404||intentional=yes}}
- {{cite journal |last1=Sung |first1=B |last2=Ravindran |first2=J |last3=Prasad |first3=S |last4=Pandey |first4=MK |last5=Aggarwal |first5=BB |title=Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. |journal=The Journal of Biological Chemistry |date=12 November 2010 |volume=285 |issue=46 |pages=35418–27 |doi=10.1074/jbc.M110.172767 |pmid=20837473 |pmc=2975165|display-authors=1}}{{retracted |||||||||||||||||doi=10.1074/jbc.A110.172767 |pmid=27496964 |pmc=4974406||intentional=yes}}
- {{cite journal |last1=Kannappan |first1=R |last2=Yadav |first2=VR |last3=Aggarwal |first3=BB |title=γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents. |journal=The Journal of Biological Chemistry |date=22 October 2010 |volume=285 |issue=43 |pages=33520–8 |doi=10.1074/jbc.M110.158378 |pmid=20720018 |pmc=2963373|display-authors=1}}{{retracted |||||||||||||doi=10.1074/jbc.A110.158378 |pmid=27496963 |pmc=4974405||intentional=yes}}
- {{cite journal |last1=Gupta |first1=SC |last2=Reuter |first2=S |last3=Phromnoi |first3=K |last4=Park |first4=B |last5=Hema |first5=PS |last6=Nair |first6=M |last7=Aggarwal |first7=BB |title=Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax. |journal=The Journal of Biological Chemistry |date=14 January 2011 |volume=286 |issue=2 |pages=1134–46 |doi=10.1074/jbc.M110.191379 |pmid=21078664 |pmc=3020720|display-authors=1}}{{retracted |||||||||||||||||||||doi=10.1074/jbc.A110.191379 |pmid=27496966 |pmc=4974408||intentional=yes}}
- {{cite journal |last1=Prasad |first1=S |last2=Yadav |first2=VR |last3=Kannappan |first3=R |last4=Aggarwal |first4=BB |title=Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK. |journal=The Journal of Biological Chemistry |date=18 February 2011 |volume=286 |issue=7 |pages=5546–57 |doi=10.1074/jbc.M110.183699 |pmid=21156789 |pmc=3037668|display-authors=1}}{{retracted |||||||||||||||doi=10.1074/jbc.A110.183699 |pmid=27496965 |pmc=4974407||intentional=yes}}
- {{cite journal |last1=Yadav |first1=VR |last2=Prasad |first2=S |last3=Gupta |first3=SC |last4=Sung |first4=B |last5=Phatak |first5=SS |last6=Zhang |first6=S |last7=Aggarwal |first7=BB |title=3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells. |journal=The Journal of Biological Chemistry |date=2 January 2012 |volume=287 |issue=1 |pages=245–56 |doi=10.1074/jbc.M111.274613 |pmid=22065587 |pmc=3249075|display-authors=1}}{{retracted |||||||||||||||||||||doi=10.1074/jbc.A111.274613 |pmid=27496967 |pmc=4974409||intentional=yes}}
- {{cite journal |last1=Takada |first1=Y |last2=Sethi |first2=G |last3=Sung |first3=B |last4=Aggarwal |first4=BB |title=Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells. |journal=Molecular Pharmacology |date=May 2008 |volume=73 |issue=5 |pages=1549–57 |doi=10.1124/mol.107.041350 |pmid=18287248|display-authors=1}} {{retracted |doi=10.1124/mol.115.041350retraction |pmid=27301881 |pmc=4931863 |intentional=yes}}
- {{cite journal |last1=Phromnoi |first1=K |last2=Reuter |first2=S |last3=Sung |first3=B |last4=Prasad |first4=S |last5=Kannappan |first5=R |last6=Yadav |first6=VR |last7=Chanmahasathien |first7=W |last8=Limtrakul |first8=P |last9=Aggarwal |first9=BB |title=A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. |journal=Molecular Pharmacology |date=February 2011 |volume=79 |issue=2 |pages=279–89 |doi=10.1124/mol.110.067512 |pmid=20930110 |pmc=3033709|display-authors=1}}{{retracted |||||||doi=10.1124/mol.115.067512retraction |pmid=27301882 |pmc=4931867||intentional=yes}}
- {{cite journal |last1=Prasad |first1=S |last2=Tyagi |first2=AK |last3=Siddik |first3=ZH |last4=Aggarwal |first4=BB |title=Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric. |journal=Frontiers in Pharmacology |date=2017 |volume=8 |pages=871 |doi=10.3389/fphar.2017.00871 |pmid=29311914|pmc=5732987 |display-authors=1}}{{retracted ||||||||doi=10.3389/fphar.2018.00400 |pmid=29697698|pmc=5912071 ||intentional=yes}}
Books- {{cite book|title=Healing Spices: How to Use 50 Everyday and Exotic Spices to Boost Health and Beat Disease|first=Bharat B.|last=Aggarwal|first2=Debora|last2=Yost|date=January 4, 2011|publisher=Sterling|isbn= 978-1402776632|url=}}
See also - Scientific misconduct
- List of scientific misconduct incidents
References1. ^1 2 {{cite journal|last1=Grens|first1=Kerry|title=Author Nets Seven Retractions|journal=The Scientist|date=February 22, 2016|url=http://www.the-scientist.com/?articles.view/articleNo/45417/title/Author-Nets-Seven-Retractions/|accessdate=October 6, 2016}}
2. ^{{cite web|title=Cancer journals retract 10 papers, flag 8 more, and apologize for the delay|url=https://retractionwatch.com/2018/09/04/cancer-journals-retract-10-papers-flag-8-more-and-apologize-for-the-delay/#more-70872|publisher=Retraction Watch|date=2018-09-04|accessdate=2018-09-04}}
3. ^{{cite web |title=Retraction Watch Database - Bharat Aggarwal |url=http://retractiondatabase.org/RetractionSearch.aspx#?auth%3dAggarwal%252c%2bBharat%2bB |website=Retraction Watch |publisher=Center for Scientific Integrity |accessdate=2019-02-25}}
4. ^1 2 {{cite journal|title=Spice Healer|last=Stix|first=Gary|journal=Scientific American|date=February 2007|volume=296|issue=2|pages=66–9|doi=10.1038/scientificamerican0207-66}}
5. ^{{cite news|url=http://naturalmedicinejournal.com/journal/2009-12/pioneering-biochemist-bharat-b-aggarwal-phd-md-anderson-cancer-center-discovering|title=Pioneering Biochemist Bharat B. Aggarwal, PhD, of the M.D. Anderson Cancer Center, on Discovering Novel and Effective Cancer Treatments|first=Karolyn A.|last=Gazella|work=Natural Medicine Journal|date=December 2009|accessdate=March 25, 2015}}
6. ^{{cite news|url=http://www.chron.com/news/houston-texas/article/In-cancer-fight-a-spice-brings-hope-to-the-table-1913487.php|title=In cancer fight, a spice brings hope to the table|first=Todd|last=Ackerman |work=Houston Chronicle|date=July 11, 2005|accessdate=March 24, 2015}}
7. ^{{cite journal|last1=Singh|first1=Seema |title=From Exotic Spice to Modern Drug?|journal=Cell|date=September 7, 2007|volume=130|issue=5|pages=765–768|doi=10.1016/j.cell.2007.08.024|pmid=17803897}}
8. ^{{cite news |last1=Baum |first1=Stephanie |title=Biotech startup raises $1M for lung cancer treatment using component of tumeric [sic] |url=https://medcitynews.com/2013/03/biotech-startup-raises-1m-for-lung-cancer-treatment-using-component-of-tumeric/ |work=Med City News |date=March 26, 2013}}
9. ^1 {{cite news|url=http://www.chron.com/news/houston-texas/article/M-D-Anderson-professor-under-fraud-probe-3360037.php|title=M.D. Anderson professor under fraud probe|first=Todd|last=Ackerman|date=February 24, 2012|work=Houston Chronicle|accessdate=March 24, 2015}}
10. ^{{cite news|title=Prominent Indian-American researcher under probe|url=http://www.deccanherald.com/content/229961/prominent-indian-american-researcher-probe.html|accessdate=October 10, 2016|publisher=Deccan Herald|date=February 25, 2012}}
11. ^{{cite news|last1=Heisel|first1=William|title=Doctor Goes After Retraction Watch, Unleashes Streisand Effect|url=http://www.centerforhealthjournalism.org/2013/04/18/doctor-goes-after-retraction-watch-unleashes-streisand-effect|accessdate=October 6, 2016|publisher=USC Annenberg School for Communication and Journalism -- Center for Health Journalism|date=April 19, 2013}}
12. ^1 {{cite journal|last1=Nybo|first1=Kristie|title=Seven Papers Retracted for Lack of Data Integrity|journal=BioTechniques|date=February 24, 2016|url=http://www.biotechniques.com/news/biotechniquesNews/biotechniques-363309.html|accessdate=October 11, 2016}}
13. ^1 {{Cite web|title = Journal retracts 7 papers by MD Anderson cancer researcher long under investigation|last=Oransky|first=Ivan|url = http://retractionwatch.com/2016/02/22/journal-retracts-7-papers-by-md-anderson-researcher-long-under-investigation/|work = Retraction Watch|access-date = 2016-02-24|date=2016-02-22}}
14. ^1 2 3 {{cite news|last1=Ackerman|first1=Todd|title=M.D. Anderson scientist, accused of manipulating data, retires|url=http://www.houstonchronicle.com/news/houston-texas/houston/article/M-D-Anderson-scientist-accused-of-falsifying-6865704.php|accessdate=October 6, 2016|publisher=Houston Chronicle|date=March 4, 2016|deadurl=yes|archiveurl=https://web.archive.org/web/20161010052727/http://www.houstonchronicle.com/news/houston-texas/houston/article/M-D-Anderson-scientist-accused-of-falsifying-6865704.php|archivedate=October 10, 2016|df=}}
15. ^{{cite journal|last1=Lewis|first1=Tanya|title=More Retractions for Cancer Researcher|journal=The Scientist|date=June 22, 2016|url=http://www.the-scientist.com/?articles.view/articleNo/46394/title/More-Retractions-for-Cancer-Researcher/|accessdate=October 10, 2016}}
16. ^{{cite web|title=Seven retractions for prominent cancer researcher brings total to 18|url=http://retractionwatch.com/category/by-author/bharat-aggarwal/|publisher=Retraction Watch|accessdate=October 6, 2016}}
17. ^{{cite journal |title=Publisher's Note |url=http://cancerres.aacrjournals.org/content/78/17/5178 |journal=Cancer Research |volume=78 |issue=17 |pages=5178 |publisher=AACR Publications |accessdate=4 September 2018|doi=10.1158/0008-5472.CAN-18-2438 |year=2018 }}
18. ^{{cite web |last1=Oransky |first1=Ivan |title=MD Anderson: No, we did not co-sponsor this cancer conference |url=https://retractionwatch.com/2018/02/05/md-anderson-no-we-did-not-co-sponsor-this-cancer-conference/ |publisher=Retraction Watch |accessdate=January 9, 2019 |date=February 5, 2018}}
19. ^{{cite news |last1=Unni |first1=Anagha |title=After 'cancer is karma' remark, Baba Ramdev to inaugurate research conference at IIT Madras |url=http://www.newindianexpress.com/nation/2018/feb/04/after-cancer-is-karma-remark-baba-ramdev-to-inaugurate-research-conference-at-iit-madras-1768314.html |accessdate=January 9, 2019 |publisher=Indian Express |date=February 4, 2018}}
20. ^{{cite web |last1=Chu |first1=Will |title=Curcumin trial retraction latest in long line for retired researcher |url=https://www.nutraingredients.com/Article/2018/04/12/Curcumin-trial-retraction-latest-in-long-line-for-retired-researcher |publisher=NutraIngredients |accessdate=January 9, 2019 |date=April 13, 2018}}
21. ^1 {{cite news |title=Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions |url=https://retractionwatch.com/2018/04/10/caught-our-notice-researcher-who-once-threatened-to-sue-retraction-watch-now-up-to-19-retractions/#more-63985 |work=Retraction Watch |date=10 April 2018}}
22. ^{{cite web |title=Database |url=http://retractiondatabase.org/RetractionSearch.aspx?AspxAutoDetectCookieSupport=1#?AspxAutoDetectCookieSupport%3d1%26auth%3dBharat%2bB%2bAggarwal |publisher=Retraction Watch |accessdate=30 May 2018}}
External links- [https://web.archive.org/web/20150812084208/http://faculty.mdanderson.org/bharat_aggarwal/ Former MD Anderson Cancer Center profile], archived August 12, 2015
{{authority control}}{{DEFAULTSORT:Aggarwal, Bharat}} 13 : Living people|American biochemists|American male scientists of Indian descent|Banaras Hindu University alumni|Cancer researchers|Indian biochemists|ISI highly cited researchers|People involved in plagiarism controversies|People involved in scientific misconduct incidents|University of California, Berkeley alumni|University of Delhi alumni|University of Texas MD Anderson Cancer Center faculty|Year of birth missing (living people) |